165 related articles for article (PubMed ID: 34785767)
21. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone.
Lutsik P; Baude A; Mancarella D; Öz S; Kühn A; Toth R; Hey J; Toprak UH; Lim J; Nguyen VH; Jiang C; Mayakonda A; Hartmann M; Rosemann F; Breuer K; Vonficht D; Grünschläger F; Lee S; Schuhmacher MK; Kusevic D; Jauch A; Weichenhan D; Zustin J; Schlesner M; Haas S; Park JH; Park YJ; Oppermann U; Jeltsch A; Haller F; Fellenberg J; Lindroth AM; Plass C
Nat Commun; 2020 Oct; 11(1):5414. PubMed ID: 33110075
[TBL] [Abstract][Full Text] [Related]
22. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
[TBL] [Abstract][Full Text] [Related]
23. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
[TBL] [Abstract][Full Text] [Related]
25. Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone.
Ogura K; Hosoda F; Nakamura H; Hama N; Totoki Y; Yoshida A; Ohashi S; Rokutan H; Takai E; Yachida S; Kawai A; Tanaka S; Shibata T
Genes Chromosomes Cancer; 2017 Oct; 56(10):711-718. PubMed ID: 28545165
[TBL] [Abstract][Full Text] [Related]
26. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
[TBL] [Abstract][Full Text] [Related]
27. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
[TBL] [Abstract][Full Text] [Related]
28. Drivers underpinning the malignant transformation of giant cell tumour of bone.
Fittall MW; Lyskjaer I; Ellery P; Lombard P; Ijaz J; Strobl AC; Oukrif D; Tarabichi M; Sill M; Koelsche C; Mechtersheimer G; Demeulemeester J; Tirabosco R; Amary F; Campbell PJ; Pfister SM; Jones DT; Pillay N; Van Loo P; Behjati S; Flanagan AM
J Pathol; 2020 Dec; 252(4):433-440. PubMed ID: 32866294
[TBL] [Abstract][Full Text] [Related]
29. Giant Cell Tumor of Bone Without Giant Cells with a Long Clinical Course: A Case Report.
Takase H; Kato I; Ito J; Kawabata Y; Okabe T; Takeyama M; Fujii S
Int J Surg Pathol; 2023 Apr; 31(2):190-194. PubMed ID: 35502834
[TBL] [Abstract][Full Text] [Related]
30. p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1.
Okubo T; Saito T; Mitomi H; Takagi T; Torigoe T; Suehara Y; Kaneko K; Yao T
Virchows Arch; 2013 Jul; 463(1):67-77. PubMed ID: 23748877
[TBL] [Abstract][Full Text] [Related]
31. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation.
Tsukamoto Y; Futani H; Kihara T; Watanabe T; Kumanishi S; Matsuo S; Hirota S; Ueda T; Yamamoto H; Yoshiya S
Pathol Res Pract; 2018 Sep; 214(9):1504-1509. PubMed ID: 29970305
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
[TBL] [Abstract][Full Text] [Related]
33. Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation.
Hasenfratz M; Mellert K; Marienfeld R; von Baer A; Schultheiss M; Roitman PD; Aponte-Tinao LA; Lehner B; Möller P; Mechtersheimer G; Barth TFE
Sci Rep; 2021 Mar; 11(1):5709. PubMed ID: 33707617
[TBL] [Abstract][Full Text] [Related]
34. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
Noh BJ; Park YK
Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971
[TBL] [Abstract][Full Text] [Related]
35. P53 expression as a prognostic marker in giant cell tumor of bone: a pilot study.
Papanastassiou I; Ioannou M; Papagelopoulos PJ; Arealis G; Mihas C; Iakovidou I; Demertzis N
Orthopedics; 2010 May; 33(5):. PubMed ID: 20506947
[TBL] [Abstract][Full Text] [Related]
36. Giant cell tumor of bonelike lesion in a Trp53 mutant mouse.
Radaelli E; Rustighi A; Scanziani E
Toxicol Pathol; 2012 Jun; 40(4):675-81. PubMed ID: 22328409
[TBL] [Abstract][Full Text] [Related]
37. Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.
Shi L; Shi J; Shi X; Li W; Wen H
J Mol Biol; 2018 May; 430(11):1562-1565. PubMed ID: 29689253
[TBL] [Abstract][Full Text] [Related]
38. [Giant cell tumor of bone-an update].
Tschavoll F; Lutteri G; Leinauer B; Mellert K; Möller P; Barth TFE
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):215-219. PubMed ID: 37985483
[TBL] [Abstract][Full Text] [Related]
39. Personalized medicine modality based on patient-derived xenografts from a malignant transformed GCTB harboring H3F3A G34W mutation.
Yafei J; Haoran M; Wenyan J; Linghang X; Kai T; Gangyang W; Zhuoying W; Jing H; Mengkai Y; Yujie T; Yingqi H; Zhengdong C
J Orthop Translat; 2021 Jul; 29():106-112. PubMed ID: 34136349
[TBL] [Abstract][Full Text] [Related]
40. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant.
Alexandrescu S; Meredith DM; Lidov HG; Alaggio R; Novello M; Ligon KL; Vargas SO
Histopathology; 2021 Jan; 78(2):265-275. PubMed ID: 32692439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
